 |
Despite a struggling economy and increased competition for private
support, the Campaign for UCSF reached its dollar goal of $1.4
billion approximately one year ahead of schedule this past month.
The achievement came on the heels of a remarkably successful
fiscal year—the fifth consecutive one in which fundraising
for the campus exceeded $200 million.
A record 24,539 donors contributed to UCSF during the fiscal
year beginning on July 1, 2003, and closing on June 30, 2004.
Totaling $253.7 million, their gifts, pledges and grants brought
the campaign tally to $1.385 billion. Additional support since
the end of June pushed the campaign total over the $1.4 billion
mark in August.
Among others, the following extraordinary commitments were
made to UCSF during the 2003-2004 fiscal year:
- The Helen Diller family's pledge of $35 million to name
a new cancer research building at the UCSF Mission Bay campus—the
largest gift ever made by individual donors in UCSF history.
- A $20 million pledge from the Atlantic Philanthropies
to support construction of the Helen Diller Family Cancer
Research Building.
- The successful conclusion of the Grove Stem Cell Challenge,
which raised more than $12 million for the UCSF Program
in Developmental and Stem Cell Biology as well as individual
UCSF stem cell investigators.
- Warren E. Buffett's gifts totaling $6.4 million to support
the work of head and neck cancer clinicians in the School
of Medicine and the School of Dentistry.
- A bequest of $5 million from UCSF School of Pharmacy alumnus
Carl Lovotti to support a variety of initiatives at the
School.
Chief among the challenges remaining in the final year of
the seven-year Campaign for UCSF is the completion of the
UCSF Mission Bay capital projects goal, which is currently
$60 million short of its $345 million target.
Gifts to this campaign priority enabled rapid development
of the new campus over the past year, including the March
opening of Arthur and Toni Rembe Rock Hall. The findings of
this building's investigators in the related fields of human
genetics, developmental biology and developmental neuroscience
are expected to lead to new treatments for psychological disorders,
neurodegenerative diseases and addictions.
"UCSF researchers have the potential to revolutionize
health science, but their best work can only happen in the
best facilities," says Andrew S. Grove, chairman of Intel
Corporation and national chair of the Campaign for UCSF. "When
it comes to the future of human health, I cannot imagine a
better investment than the UCSF Mission Bay campus."
|
|
